New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

March 20, 2018 Leave a comment 2,390 Views

Veracyte, Inc. today announced that new data presented at ENDO 2018, the annual meeting of the Endocrine Society, suggest that the Afirma Genomic Sequencing Classifier (GSC) can help significantly more

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Endocrine Society

New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

Researchers combine single cell sequencing data with spatial information to create unprecedented cellular maps of tissues

MGcount – a total RNA-seq quantification tool to address multi-mapping and multi-overlapping alignments ambiguity in non-coding transcripts

Zero-preserving imputation of single-cell RNA-seq data

Featured RNA-Seq Job – Computational Scientist

Veranome Biosystems and Cold Spring Harbor Laboratory Enter Collaboration and Licensing Agreement to Develop Advanced In-Situ Sequencing Technologies

iDIRECT – disentangling direct from indirect relationships in association networks

small RNA sequencing suggests BPA exposure of the placenta could affect fetal brain development